SUBSCRIBE
SUBSCRIBE
News   FDA

US FDA Panel Rejects Forest Laboratories, Inc., Nycomed Lung Drug

April 8, 2010 | 
1 min read
Reuters -- Forest Laboratories Inc suffered a setback on Wednesday as a U.S. advisory panel voted against recommending approval of an experimental drug to treat a common and deadly lung disorder.
FDA Approvals Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
halftone magazine style banner, dislike, negative rating, hand thumbs down
Complete response letters
Fortress, Sentynl Fail To Secure FDA Nod in Rare Pediatric Disease
October 1, 2025
 · 
2 min read
 · 
Tristan Manalac
External view of the U.S. Capitol building
Government
US Government Shuts Down, FDA Closed for New Applications
October 1, 2025
 · 
4 min read
 · 
Annalee Armstrong
Marburg, Germany - July 6, 2013: Marburg Office of Swiss multinational company Novartis AG
Approvals
Novartis Secures First FDA Approval of Oral BTK Inhibitor for Chronic Hives
October 1, 2025
 · 
2 min read
 · 
Tristan Manalac
Podcast
M&A Picks Up, Walmsley Moves On, Pfizer’s MFN Deal and Hope for Huntington’s
October 1, 2025
 · 
2 min read
 · 
Heather McKenzie